In a mouse implantation model for mammary carcinoma, the complete loss of APLN expression from tumor cells (by APLN-KD) and the TME (using APLN-KO) led to a decrease in tumor vessel density and tumor volumes [46]. The gene discussed is APLN; the disease is neoplasm.